Alexander Calls For Administration To Clarify Position On Patient Access To Personal Health Information

Thursday, February 20, 2014

Senator Lamar Alexander on Thursday asked Health and Human Services Secretary Kathleen Sebelius to clarify the administration’s position on patient access to personal health information.

The FDA last year said in a warning letter to genetic test maker 23andMe it was taking action to stop the company from marketing certain tests directly to consumers that FDA does not trust individuals with test results, that there is a “risk that a direct-to-consumer test result may be used by a patient to self-manage.”

Earlier this month, Secretary Sebelius said in an HHS press release, “Information like lab results can empower patients to track their health progress, make decisions with their healthcare professionals, and adhere to important treatment plans.”

In a letter to Secretary Sebelius, Senator Alexander said, “Some centers within your department seem to be in agreement with the goal to make personal health information available directly to consumers, as shown by the final rule allowing clinical laboratories to give complete test reports directly to patients, published by the Office of Civil Rights, Center for Medicare and Medicaid Services, and Center for Disease Control and Prevention.  …However, your statement and the final regulation appear to be in direct conflict with the Food and Drug Administration’s warning letter from November 22, 2013, to 23andMe, Inc., a direct-to-consumer genetic testing laboratory.  FDA stated one reason it was taking action to stop 23andMe is that FDA does not trust individuals with test results, because results are not adequately understood by patients.”

Senator Alexander said the conflict “will slow down the access to or availability of novel diagnostics and targeted therapies.” He added, “Targeted drug therapies rely on the availability of a wide array of diagnostic products, and consumers who want to take control of their health should have the right to their personal information to help in making personal health care decisions.”

Senator Alexander asked Secretary Sebelius to state the HHS position on greater direct access to personal health information for patients and also requested the criteria used to evaluate the types of tests indicated in the conflicting statements.

The full text of the letter is below:

February 20, 2014

The Honorable Kathleen Sebelius

Secretary of Health and Human Services

U.S. Department of Health and Human Services

330 Independence Avenue, SW

Washington, DC 20201

Dear Secretary Sebelius:

I write today to ask for clarity on conflicting decisions made by your Department regarding consumer access to personal health information.  This is the information age; individuals should have direct access to personal health information, and federal policies should clearly support that goal. Recent actions by the Food and Drug Administration (FDA) indicate a resistance to the importance of personal health information. 

Some centers within your department seem to be in agreement with the goal to make personal health information available directly to consumers, as shown by the final rule allowing clinical laboratories to give complete test reports directly to patients, published by the Office of Civil Rights, Center for Medicare and Medicaid Services, and Center for Disease Control and Prevention.[1]  In a press release on February 4, 2014, you stated, “Information like lab results can empower patients to track their health progress, make decisions with their healthcare professionals, and adhere to important treatment plans.”[2]  However, your statement and the final regulation appear to be in direct conflict with the Food and Drug Administration’s warning letter from November 22, 2013, to 23andMe, Inc., a direct-to-consumer genetic testing laboratory.  FDA stated one reason it was taking action to stop 23andMe is that FDA does not trust individuals with test results, because results are not adequately understood by patients. FDA cautioned: “risk of serious injury or death is known to be high when patients are either non-compliant or not properly dosed,” and there is a “risk that a direct-to-consumer test result may be used by a patient to self-manage.” [3]

These are two conflicting actions from your Department in just a few months’ time and raise questions about your agency’s commitment to making personal health information available to support medical innovation. The conflicting decisions coming from agencies within your Department will slow down the access to or availability of novel diagnostics and targeted therapies.  Targeted drug therapies rely on the availability of a wide array of diagnostic products, and consumers who want to take control of their health should have the right to their personal information to help in making personal health care decisions.

What is your Department’s position on greater direct access to personal health information for patients? Further, please describe what criteria were used to evaluate the types of tests described in these two actions that resulted in such opposite outcomes.

I appreciate your prompt attention to this request. If you have any further questions, please have your staff contact Grace Stuntz or Alicia Hennie on my staff at (202)-224-6770.

Sincerely,

Lamar Alexander

Ranking Member, Senate Committee on Health, Education, Labor, and Pensions


Morning Pointe Residents Put Contest Earnings Toward Alzheimer's Fundraiser

Morning Pointe of Chattanooga at Shallowford was the regional winner of the corporate Spring Fling contest.  The assisted community was rewarded with $550 for a celebration.  Instead of having a party, the directors of Morning Pointe of Chattanooga knew that residents would want to share their prize with the community so they decided to put it towards one of their biggest ... (click for more)

CHI Memorial Medical Group Welcomes David Castrilli, M.D. To CHI Memorial Internal Medicine Associates

CHI Memorial Medical Group announces David Castrilli, M.D. has joined CHI Memorial Internal Medicine Associates.  Dr. Castrilli received his medical degree from St. George’s School of Medicine. He completed his residency at University of Tennessee, Chattanooga.  His specialty is internal medicine. “We are pleased to welcome Dr. Castrilli into CHI Memorial Internal ... (click for more)

Boy, 4, Struck By Vehicle Near Tunnel Boulevard

A four-year-old boy was struck by a vehicle near Tunnel Boulevard on Saturday afternoon. A t approximately 4:20 p.m.,  the Chattanooga Police Department responded to 3400 Through St. on a c hild struck by a vehicle.  T he victim was conscious when officers arrived. He was transported to a local hospital. I nvestigators are continuing to compile ... (click for more)

Assessor Bennett, Former Assessor Ramsey In Jetton Camp For Assessor Of Property

Assessor of Property Bill Bennett and former Assessor Claude Ramsey recommended Sterling Jetton as the next assessor at a breakfast fundraiser at Wally's Restaurant in East Ridge on Saturday morning. Mr. Jetton, who spent 27 years in the assessor's office, is running against County Commissioner Marty Haynes in the March 1 Republican primary. Noting the political heavyweights ... (click for more)

DWT Is DUI

A routine narrative of a DUI arrest report goes something like this:   The defendant was operating a motor vehicle in the 00 block of sonsoroad. The driver was weaving back and forth across the marked roadway. The defendant drove through a stop sign. Was stopped at an intersection despite the traffic light was green. Entered the lane of another vehicle and caused a ... (click for more)

Roy Exum: ‘Black Lives Matter’ To Me

Between the time a 14-year-old boy was shot four times late Sunday afternoon on 7 th Street and a 20-year-old reputed gang member was killed Tuesday night on Willow Street, there appeared in my morning reading an article on “Black Lives Matter.” I read it because I mourn over what the black community continues to struggle with in both our city and our country. It is an article, ... (click for more)